Publisher
Springer Science and Business Media LLC
Reference26 articles.
1. Guidelines for Blood Donor Selection and Blood Donor Referrals. National Blood Transfusion Council. https://naco.gov.in/national-blood-transfusion-council-nbtc-0 (2017).
2. Landry, M. L. Parvovirus B19. Microbiol Spectr. 4, 1. https://doi.org/10.1128/microbiolspec.DMIH2-0008-2015 (2016).
3. Juhl, D. Parvovirus B19: What is the relevance in transfusion medicine?. Front. Med. 5, 4. https://doi.org/10.3389/fmed.2018.00004 (2018).
4. US Food and Drug Administration. Nucleic acid testing (NAT) to reduce the possible risk of parvovirus B19 transmission by plasma-derived products. Rockville (MD): FDA Center for Biologics Evaluation and Research. FDA draft guidance for industry (2008).
5. Corcioli, F. et al. Tissue persistence of parvovirus B19 genotypes in asymptomatic persons. J. Med. Virol. 80, 2005–2011. https://doi.org/10.1002/jmv.21289 (2008).